MedDataX Logo

Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole

NCT ID: NCT00615914

Last Updated: 2014-07-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1645 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The survey is conducted to collect safety and effectiveness information on the use of Pramipexole for long time of period in daily clinical settings in Japan.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

NCT00613301

Parkinson Disease
COMPLETED

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

NCT02177357

Parkinson Disease
COMPLETED PHASE3

Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease

NCT00539214

Parkinson Disease
COMPLETED

Special Survey on PD Patients With Renal Dysfunction

NCT00613756

Parkinson Disease
COMPLETED

A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period

NCT00560508

Parkinson Disease
COMPLETED PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with Parkinson's disease

Exclusion Criteria

Patients should have been treated according to the Japanese insert slip
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site

Agano, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Aizu-Wakamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Akashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Asahikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Asakura, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Azumino, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Bandō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Beppu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Bihoro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Chikusei, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Chūō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Date, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ebetsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ebina, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fuchū, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fuji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujieda, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujisawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujiyoshida, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukui, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ginowan, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hachinohe, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hadano, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hagahama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hakodate, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hamada, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hayashima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Higashimurayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Higashiosaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Higashiyamato, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Himeji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hiratsuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hirokawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hirosaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hōfu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ichikikushikino, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ichinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ichinoseki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iijima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iizuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ikeda, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ikoma, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ina, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Inazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Inba, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Inuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Isesaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Itoigawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iwaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iwata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Jōetsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kahoku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kajiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kakegawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kakogawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kamisu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kamogawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kanazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kanegusuku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kannonji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Karatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kashima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kashiwa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kashiwazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kasukabe, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Katō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kawagoe, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kawatana, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kikugawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kirishima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kitakyushu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kiyose, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kiyotake, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kizugawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kobayashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kochi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kodaira, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kofu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kokubunji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Komae, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Komatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Komoro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koshikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kōriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kōshi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kōtari, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kurashiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kurayoshi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kure, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kurume, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kushiro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kutchan, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kuwana, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Maebaru, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Maebashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Maibara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Maizuru, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Marugame, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsuda, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsudo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsue, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsumoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mibu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Minakami, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Minamata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Minobu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Misashino, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mito, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miyaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miyakonojō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mooka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Moriguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Morioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Moriya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Moriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Motona, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mukai-awagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Muroran, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagakute, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nangōku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Narita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Narutō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nichinan, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Niihama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nikkō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishigō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishio, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishitōkyō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nobeoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Noboribetsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Numazu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Obama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Obihiro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Odawara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ohzu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ojiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Omaezaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Omuta, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Onomichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōdate, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōfunato, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōgaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōiso, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōkawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōmura, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōnojō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōtsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōzu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sado, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sakaidechō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sakata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sanjō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sano, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sanyōonoda, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sasebo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Seijō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shimabara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shimonoseki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shimotsuke, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shingū, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shinshiro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shūnan, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Soo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Suita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tajimi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takanabe, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takasago, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takatsuki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takehara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toda, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Togitsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokoname, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Adachi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Bunkyo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Chiyoda-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Edogawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Itabashi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Katsushika-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Kita-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Minayo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Nakano-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Nerima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Ota-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Setagaya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Shinagawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Shinjuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Suginami-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Toshima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tomakomai, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tomiai, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tondabayashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toride, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyoake, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyokawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyonaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyooka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tōon, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tsubata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tsuchiura, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tsukuba, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tsuruoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ueda, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Uji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ujo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Urayasu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Uruma, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Utsunomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Wajiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Wakayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yamamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yanai, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yao, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yashiro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yazu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yokkaichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yokote, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yoro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yoshinogawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yufu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Zama, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

248.547

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).
NCT00601523 COMPLETED PHASE3
Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
NCT01525641 COMPLETED
Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice
NCT01061567 COMPLETED
a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients
NCT01361009 COMPLETED
Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms
NCT00297778 COMPLETED PHASE4
The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease
NCT01470859 COMPLETED NA
Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole
NCT02236728 COMPLETED
Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease
NCT00240409 COMPLETED PHASE3
Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment
NCT00651183 COMPLETED
Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease
NCT01673724 COMPLETED PHASE4
A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients
NCT00402233 COMPLETED PHASE4
Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
NCT00479401 COMPLETED PHASE3
Pivotal Study in Advanced Parkinsons Disease Patients
NCT00466167 COMPLETED PHASE3
Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease
NCT02233023 COMPLETED PHASE4
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
NCT03845387 COMPLETED PHASE2
A Study to Evaluate in Patients With Parkinsonian Type Disorders
NCT03683225 ACTIVE_NOT_RECRUITING PHASE2
SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease
NCT00335166 COMPLETED PHASE3
Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)
NCT00321854 COMPLETED PHASE4
Prevent Cognitive Decline in GBA-associated Parkinson's Disease
NCT07055087 NOT_YET_RECRUITING PHASE2
Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
NCT02157714 COMPLETED PHASE1
Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease
NCT01097421 COMPLETED
Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients
NCT02073981 COMPLETED
Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients
NCT01191944 COMPLETED PHASE3
Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease
NCT00558025 COMPLETED PHASE3
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
NCT01723904 COMPLETED PHASE3